Design: We examined the degree to which UK vascular units met this standard and whether rapid interventions were associated with procedural risks.
Introduction
Stroke is the second largest cause of death in the world causing 6,700,000 deaths each year 1 and is the fourth largest cause of death in the UK. 2 There are more than 150,000 new strokes in the UK each year. Of these, one in eight are fatal within 30 days, while one in four are fatal within a year. 2 Approximately 15% of ischaemic strokes are preceded by a transient ischaemic attack (TIA). 2 Thromboembolism from an ipsilateral carotid artery stenosis is responsible for about 20% of all strokes. 2, 3 Two landmark randomised trials; the North American Symptomatic Carotid Endarterectomy Trial (NASCET) 4 and the European Carotid Surgery Trial (ECST), 5 demonstrated the benefit of performing carotid endarterectomy (CEA) in symptomatic patients with a 50-99% internal carotid artery (ICA) stenosis. An individual patient meta-analysis of data from NASCET and ECST subsequently showed that maximum benefit was conferred if CEA was performed within 14 days of randomisation. 6 Based on these findings, international guidelines increasingly recommend that CEA be performed within 2 weeks of an ischaemic cerebrovascular event (TIA or minor stroke) in symptomatic patients with ipsilateral high-(70-99%) or moderate-degree (50-69%) carotid artery stenoses.
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In addition, there is growing evidence that the natural history risk of stroke in the first few days after TIA onset is much higher than previously thought in patients with 50-99% ICA stenoses. In a review of the published literature, eight natural history studies observed that the risk of stroke in the hyperacute period was 5-8% at 48 hours, 17% at 72 hours, 8-22% at 7 days and 11-25% at 14 days 11 again emphasizing the need for expedited CEA.
Several studies have evaluated the delay between onset of symptoms to undergoing CEA. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Most [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [23] [24] [25] have demonstrated that only a minority of symptomatic patients undergo CEA within the recommended 2-week period from the index event. The reasons for excess delays to CEA are multifactorial including: access to carotid imaging, long waiting times to theatre, 16, 17 delays in speed of referral to vascular surgeons 13, 14, 16, 25 and/or delays due to medical comorbidities (e.g. angina pectoris, cardiac workup, etc.). 15, 16, 18, 21 In addition, some surgeons have raised concerns about incurring a higher perioperative risk of stroke and/or death if CEA is performed soon after the neurological event 26 , especially in the first 48 hours 27 . Conversely, studies which have reported delays of 12 weeks or more in performing CEA have observed recurrent stroke rates as high as 32%. 28 Because of these very high rates of recurrent stroke, it has been suggested that vascular services with excessive delays in delivering CEA should probably not perform carotid revascularization procedures.
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In the UK, around 4000-5000 patients undergo CEA each year. The National Carotid 3, 13 .
Materials and Methods
The study is based on data extracted from the National Vascular Registry ( In the remaining 31,388 patients, there were 4,268 patients who underwent CEA for asymptomatic disease (13.6%) and these were also excluded. Finally, it was necessary to exclude a further 3,885 patients from analyses because there was incomplete data regarding date of the index symptom, referral date and treatment date for each patient.
The characteristics of the 23,235 remaining patients are summarised in with a corresponding fall in the prevalence of 70-90% stenoses.
The median delay from index symptom to undergoing CEA reduced from 22 days (IQR 10- The overall postoperative 30-day stroke and death rates after CEA were 1.85% (95% CI 1.67 to 2.02) and 0.83% (95% CI 0.71 to 0.94). The combined 30-day stroke and death rate was 2.31% (95% CI 2.11 to 2.50). The rates remained stable throughout the 6-year time period. Table 3 shows the relationship between the time from symptom to surgery and these three outcomes. There is no evidence that the risk of death is associated with the length of delay, but there is evidence of an increased risk of stroke within 30-days for CEA performed in the first 2 days after the index symptoms compared to operations performed between 3 and 7 days after. There is no evidence that longer intervals from index symptom to surgery are associated with the rate of these three outcomes.
Discussion
Following publication of ECST and NASCET, the 1995 American Heart Association (AHA) Based on the CETC meta-analysis, CEA conferred a 30% absolute risk reduction in stroke at five years when CEA was performed within 2 weeks in patients with a 70-99% symptomatic carotid stenosis. 6 This benefit almost halved (ARR 17%) when CEA was performed between 2-4 weeks and was reduced to nearly a third (ARR 11%) when CEA was delayed by more than four weeks. 6 In addition, a review of 8 natural history studies has now shown that the early risk of stroke may be even higher than previously thought, with some studies reporting recurrent stroke rates of 5-8% at 48 hours, 17% at 72 hours, 8-22% at 7 days and 11-25% at 14 days 11 .
However, there have been concerns that performing CEA in the early time period after onset of symptoms may be associated with a significant increase in the procedural risk, which might then offset any benefit accruing to the patient 26 . These concerns appeared to be corroborated by one of the first national audits of practice. In the 2012 Swedish Vascular Audit (SwedVasc), only 6% of patients underwent CEA within 48 hours of symptom, but they incurred a 11.5% risk of death/stroke at 30-days 27 . Overall 63% underwent CEA within 14 days of symptom onset. After 48 hours had elapsed, procedural risks after CEA ranged between 3-5% 27 .
The current study, therefore, is only the second national audit to report on outcomes, stratified for delays to CEA and a number of key findings are worthy of comment. First; the time from onset of the index symptom to undergoing CEA has continued to decrease (year on Third, more than 40% of all symptomatic patients undergoing CEA in the UK in 2014 did not undergo their operation within 14 days. This is disappointing and requires further analysis.
Somewhat disappointingly, the main three reasons neither changed in ranking, nor in their magnitude over the three-year time period 30, 34 . The commonest reason was a delay in referral to the vascular surgeon. The second commonest was a delay in the patient seeking medical advice, while the third commonest were delays in accessing carotid imaging. In short, in addition to improving patient awareness about seeking urgent medical advice after symptom onset, Commissioners, Administrators and Clinicians in both primary and secondary care must work together to reconfigure referral, imaging and treatment pathways to ensure that patients can access CEA more rapidly. Evidence suggests that this can lead to significant reductions in the time from symptom onset to undergoing CEA 22 .
Fourth, this audit has shown that the time from symptom onset to undergoing CEA does not seem to be affected by the volume of CEAs performed in the hospital.
Previous reports have suggested that there may be an under provision of CEA in the UK.
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These reports have determined that at least 10,000 patients who suffer a TIA or a minor stroke in the UK each year could potentially benefit from CEA. Despite this, the number of CEAs performed for symptomatic carotid stenosis represents half this number. The data from the current NVR report, therefore, supports the conclusions reached in previous reports 3, 13 If all 10,000 patients were to undergo CEA within 2 weeks of symptom onset, about 1,100
ipsilateral ischaemic strokes would be prevented at 5 years.
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This study does have potentially important limitations. Firstly, it only includes symptomatic patients who eventually underwent CEA. Symptomatic patients deemed to be at 'high surgical risk' and who were not offered surgery were not included. Secondly, a small percentage of patients undergoing CEA during this time period may not have been registered in the UK National CEA Clinical Audit. Thirdly, a significant minority of patients did not have complete data relating to all the time points in the patient pathway entered onto the NVR. Finally, the reasons for not performing CEA within 14 days of symptom onset were provided by vascular surgeons and (for the most part) surgeons were also responsible for reporting death/stroke rates at 30-days.
In conclusion, the NVR has reported sustained national improvements in the delivery of CEA Year of procedure Figure 3 : Changes in the proportion of patients whose time from index symptom to surgery exceeded 14 days among NHS trusts that were categorised by annual surgical volume as low (<34 pa), medium (35-54 pa) or high volume (>55 pa). 
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